Clinical Brief: Genomic & Phenotypic Integration Report
Clinical Brief: Genomic & Phenotypic Integration Report Date: May 2026 Clinical Profile: Triple-Positive for Antiphospholipid Autoantibodies | Chronic Mild Immune Thrombocytopenia (ITP) Section 1: Comprehensive Chrono-Protocol Architecture The total supportive metabolic regimen is clinically organized below by timing and pathway targets, structured intentionally to avoid absorption crossover and preserve complete clearance margins for prescribed pharmaceutical interventions. This serves as the clinical dashboard for current intake parameters. 1.1 Waking / Empty Stomach Protocol R-Alpha Lipoic Acid (R-ALA): Waking redox cofactor; STING pathway regulation and Phase II master glutathione recycler. Biocyte Liposomal Glutathione (200mg): Direct intracellular redox substrate; direct CTH transsulfuration bypass. 1.2 Breakfast Protocol (with Fats / Lipid Carrier Media) Cardio Aspirin (80mg) [Prescribed Therapy]: Absolute priority antiplatelet hardware baseline; targeted risk management aga...